Not facing any significant IPR challenges in India: Abbott

American pharmaceuticals giant Abbott has told the US government that it is not facing any significant challenge with respect to intellectual property rights, as is being alleged by a section of......

Abbott adds local expertise to its global resource

Antacid Digene and pain drug Brufen have been among the top in their categories in India for decades. But not their manufacturer, Abbott. Until, that is, its acquisition of Piramal Healthcare's......

Where innovation creates value

Value innovation can help improve efficiency across the organisation and deliver better results, says Richard Lee. In the second decade of the 21st century, it is imperative that governments......

2009: How it was for global biz

Clouds of economic recession and a stormy labour market had cast a dark shadow at the dawn of 2009. From thousands of job losses to historic bankruptcies to Dubai debt crisis, the year had more......